Open AccessThe efficacy of high-power short-duration radiofrequency for atrial fibrillation ablation
Author(s) -
Peng Zhang,
Liang Ma,
Fei Wang,
Liang Shi
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025569
Subject(s) - medicine , atrial fibrillation , medline , radiofrequency ablation , meta analysis , clinical trial , systematic review , catheter ablation , intensive care medicine , ablation , political science , law
Background: Studies comparing data between the high-power short-duration radiofrequency (HPSR) and low power longer duration therapy were limited and inconsistent. Therefore, we conduct a high-quality systematic review and meta-analysis to assess the efficacy and safety of HPSR on outcomes for patients with atrial fibrillation (AF). Methods: The online literature is searched using the following combination of medical subject heading terms: “high-power” OR “high power” AND “radiofrequency” AND “atrial fibrillation.” MEDLINE (PubMed), EMBASE (OVID), Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science (ISI database) will be searched without any language restrictions. All clinical trials to assess the efficacy and safety of HPSR in the treatment of atrial fibrillation will be considered eligible for analysis. The present study will be performed by Review Manager Software (RevMan Version 5.3, The Cochrane Collaboration, Copenhagen, Denmark). Ethical approval and patient consent are not required because this study is a literature-based study. Results: This study expects to provide credible and scientific evidence for the efficacy and safety of HPSR on outcomes for patients with AF. Registration number: 10.17605/OSF.IO/WAEBN.